Clinical trial finds a new therapy to lower cholesterol and stabilise plaques associated with heart attack
A novel new therapy has been found to reduce harmful plaque in arteries and change its composition so it is less likely to rupture and cause a heart attack, following a clinical trial led by the Victorian Heart Institute (VHI) at Monash University. Read the media release here.
Learn more about the Victorian Heart Hospital.
Learn more about the Victorian Heart Institute.
News of the new hospital: https://www.monash.edu/medicine/enterprise/our-partnerships/projects/about-the-victorian-heart-hospital
About Monash University:
Monash University is Australia’s largest university with more than 80,000 students. In the 60 years since its foundation, it has developed a reputation for world-leading high-impact research, quality teaching, and inspiring innovation.
With four campuses in Australia and a presence in Malaysia, China, India, Indonesia and Italy, it is one of the most internationalised Australian universities.
As a leading international medical research university with the largest medical faculty in Australia and integration with leading Australian teaching hospitals, we consistently rank in the top 50 universities worldwide for clinical, pre-clinical and health sciences.